Analysts forecast that Acadia Healthcare Company Inc (NASDAQ:ACHC) will announce sales of $796.87 million for the current quarter, Zacks reports. Eight analysts have provided estimates for Acadia Healthcare’s earnings. The highest sales estimate is $805.00 million and the lowest is $781.74 million. Acadia Healthcare reported sales of $765.74 million during the same quarter last year, which would suggest a positive year over year growth rate of 4.1%. The firm is expected to report its next earnings results on Monday, July 29th.
On average, analysts expect that Acadia Healthcare will report full year sales of $3.17 billion for the current fiscal year, with estimates ranging from $3.12 billion to $3.20 billion. For the next fiscal year, analysts anticipate that the firm will report sales of $3.34 billion, with estimates ranging from $3.27 billion to $3.39 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover Acadia Healthcare.
Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.04. Acadia Healthcare had a negative net margin of 6.50% and a positive return on equity of 7.33%. The company had revenue of $760.60 million during the quarter, compared to analyst estimates of $762.02 million. During the same period last year, the firm posted $0.52 EPS. Acadia Healthcare’s revenue for the quarter was up 2.5% compared to the same quarter last year.
A number of research firms have issued reports on ACHC. ValuEngine raised shares of Acadia Healthcare from a “strong sell” rating to a “sell” rating in a research report on Wednesday, April 24th. BidaskClub lowered shares of Acadia Healthcare from a “sell” rating to a “strong sell” rating in a research report on Wednesday, March 27th. Deutsche Bank set a $32.00 price target on shares of Acadia Healthcare and gave the stock a “hold” rating in a research report on Thursday, May 2nd. BMO Capital Markets raised their price target on shares of Acadia Healthcare from $33.00 to $36.00 and gave the stock a “market perform” rating in a research report on Wednesday, May 1st. Finally, Zacks Investment Research raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and set a $30.00 price target for the company in a research report on Monday, February 18th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $36.80.
ACHC traded down $0.84 during trading on Tuesday, reaching $33.01. 14,784 shares of the company’s stock were exchanged, compared to its average volume of 703,851. Acadia Healthcare has a 1 year low of $24.27 and a 1 year high of $45.35. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 1.55. The firm has a market capitalization of $2.99 billion, a PE ratio of 14.73, a P/E/G ratio of 1.80 and a beta of 0.64.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Marshall Wace North America L.P. acquired a new stake in shares of Acadia Healthcare during the 1st quarter worth approximately $1,342,000. Clearbridge Investments LLC acquired a new stake in shares of Acadia Healthcare during the 1st quarter worth approximately $12,709,000. Nordea Investment Management AB grew its stake in shares of Acadia Healthcare by 1.3% during the 1st quarter. Nordea Investment Management AB now owns 140,136 shares of the company’s stock worth $4,107,000 after purchasing an additional 1,758 shares during the period. Maverick Capital Ltd. grew its stake in shares of Acadia Healthcare by 8.1% during the 1st quarter. Maverick Capital Ltd. now owns 89,770 shares of the company’s stock worth $2,631,000 after purchasing an additional 6,700 shares during the period. Finally, Man Group plc grew its stake in shares of Acadia Healthcare by 63.7% during the 1st quarter. Man Group plc now owns 51,922 shares of the company’s stock worth $1,522,000 after purchasing an additional 20,199 shares during the period.
About Acadia Healthcare
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
Featured Article: How to Trade Using Analysts Ratings
Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.